1.22 USD
-0.02 (-1.61%)
Overall SURG gets a fundamental rating of 1 out of 10. We evaluated SURG against 22 industry peers in the Wireless Telecommunication Services industry. SURG may be in some trouble as it scores bad on both profitability and health. SURG is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year SURG has reported negative net income.
- In the past year SURG has reported a negative cash flow from operations.
- SURG had negative earnings in 4 of the past 5 years.
- In multiple years SURG reported negative operating cash flow during the last 5 years.
1.2 Ratios
- SURG's Return On Assets of -289.89% is on the low side compared to the rest of the industry. SURG is outperformed by 95.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -289.89% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-47.87%
ROA(5y)-71.76%
ROE(3y)-79.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for SURG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- SURG does not have a ROIC to compare to the WACC, probably because it is not profitable.
- SURG has more shares outstanding than it did 1 year ago.
- SURG has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for SURG is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -13.54, we must say that SURG is in the distress zone and has some risk of bankruptcy.
- SURG's Altman-Z score of -13.54 is on the low side compared to the rest of the industry. SURG is outperformed by 95.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.54 |
ROIC/WACCN/A
WACC8.78%
2.3 Liquidity
- SURG has a Current Ratio of 0.52. This is a bad value and indicates that SURG is not financially healthy enough and could expect problems in meeting its short term obligations.
- SURG has a Current ratio of 0.52. This is amonst the worse of the industry: SURG underperforms 86.36% of its industry peers.
- SURG has a Quick Ratio of 0.52. This is a bad value and indicates that SURG is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of SURG (0.41) is worse than 86.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.41 |
3. Growth
3.1 Past
- The earnings per share for SURG have decreased strongly by -87.61% in the last year.
- SURG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.75%.
- The Revenue has been growing by 18.83% on average over the past years. This is quite good.
EPS 1Y (TTM)-87.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.32%
Revenue 1Y (TTM)-39.75%
Revenue growth 3Y6.01%
Revenue growth 5Y18.83%
Sales Q2Q%291.64%
3.2 Future
- The Earnings Per Share is expected to grow by 42.27% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 49.06% on average over the next years. This is a very strong growth
EPS Next Y44.42%
EPS Next 2Y42.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.09%
Revenue Next 2Y49.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for SURG. In the last year negative earnings were reported.
- SURG is valuated rather expensively with a Price/Forward Earnings ratio of 21.75.
- SURG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SURG is more expensive than 72.73% of the companies in the same industry.
- SURG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.75 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- SURG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as SURG's earnings are expected to grow with 42.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.27%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- SURG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SURGEPAYS INC / SURG FAQ
Can you provide the ChartMill fundamental rating for SURGEPAYS INC?
ChartMill assigns a fundamental rating of 1 / 10 to SURG.
Can you provide the valuation status for SURGEPAYS INC?
ChartMill assigns a valuation rating of 2 / 10 to SURGEPAYS INC (SURG). This can be considered as Overvalued.
What is the profitability of SURG stock?
SURGEPAYS INC (SURG) has a profitability rating of 0 / 10.
What is the expected EPS growth for SURGEPAYS INC (SURG) stock?
The Earnings per Share (EPS) of SURGEPAYS INC (SURG) is expected to grow by 44.42% in the next year.